Experienced in Tetanus

Ates H. Kara

Ankara, TR 
Experienced in Tetanus
Ankara, TR 
OverviewLocationsClinical Research

Overview

Ates Kara practices in Ankara, Turkey. Mr. Kara is rated as an Experienced expert by MediFind in the treatment of Tetanus. His top areas of expertise are Multisystem Inflammatory Syndrome in Children (MIS-C), Febrile Neutropenia, Infantile Neutropenia, Osteotomy, and Bone Marrow Transplant.

His clinical research consists of co-authoring 158 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Tetanus.

Gender
Male

Locations

Ankara, Turkey
Other Locations
Bakırköy Prof. Dr. Mazhar Osman Mental Health and Nervous Disorders Training and Research Hospital, Türkiye
Istanbul, Turkey
Sancar, Turkey
Adapazari, Turkey
Korucuk, Turkey
Altindag, 06100, Turkey
Kosekoy, Turkey
Ihlas Marmara Evleri - I. Kisim, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

An Open-Label, Multicenter, Parallel-Group, Randomized, Phase III Study to Evaluate the Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19
An Open-Label, Multicenter, Parallel-Group, Randomized, Phase III Study to Evaluate the Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19
Enrollment Status: Unknown
Publish Date: February 01, 2021
Intervention Type: Drug
Study Drugs: Favipiravir, Hydroxychloroquine, Azithromycin
Study Phase: Phase 3

158 Total Publications

Infectious complications in pediatric acute lymphoblastic leukemia treatment: A comparison of ALL-IC BFM 2009 vs. modified St. Jude total XV in a single-center retrospective cohort study.
Infectious complications in pediatric acute lymphoblastic leukemia treatment: A comparison of ALL-IC BFM 2009 vs. modified St. Jude total XV in a single-center retrospective cohort study.
Journal: Leukemia research
Published: July 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kara's expertise for a condition
ConditionClose
      View All 8 Advanced Conditions
      View All 51 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile